Trial Profile
Botulinum toxin type A Block for the sphenopalatine ganglion in chronic rhinosinusitis With nasal polyposis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Feb 2022
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Nasal polyps; Rhinosinusitis
- Focus Adverse reactions
- 12 Mar 2019 Status changed from active, no longer recruiting to completed.
- 04 Sep 2018 Planned End Date changed from 1 Jun 2018 to 1 Dec 2018.
- 04 Sep 2018 Status changed from recruiting to active, no longer recruiting.